Not applicableStudy completedNCT04486742What this trial is testingBrief Cognitive Behavioral Therapy to Treat Itch Rumination "Itch CBT" in EczemaWho this might be right forAtopic Dermatitis Northwestern University 20
Not applicableStudy completedNCT03673059What this trial is testingClinical Trial to Assess the Effects of Topical Lotions on Changes in the Skin Microbiome and Associations With ItchWho this might be right forMicrobiota Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. 91
Not applicableStudy completedNCT00407979What this trial is testingComparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and PsoriasisWho this might be right forAtopic DermatitisPsoriasis National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)UnknownNCT04413942What this trial is testingEvaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis Oneness Biotech Co., Ltd. 99
Not applicableLooking for participantsNCT05584488What this trial is testingAllergy and Immunology Natural History StudyWho this might be right forImmune DeficiencyImmune Dysregulation DisorderAllergic Inflammation Columbia University 10,000
Large-scale testing (Phase 3)Study completedNCT01840605What this trial is testingA Confirmatory Study of TAU-284 in Pediatric Patients With Atopic DermatitisWho this might be right forDermatitisAtopic Tanabe Pharma Corporation 303
Testing effectiveness (Phase 2)Study completedNCT05769946What this trial is testingHemay005 in Adult With Atopic DermatitisWho this might be right forHemay005, Atopic Dermatitis Ganzhou Hemay Pharmaceutical Co., Ltd 79
Testing effectiveness (Phase 2)Study completedNCT06058000What this trial is testingQLM3003 Ointment in Participants With Mild or Moderate Atopic DermatitisWho this might be right forAtopic Dermatitis Qilu Pharmaceutical Co., Ltd. 120
Not applicableWithdrawnNCT04965233What this trial is testingUsing a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant PhenotypesWho this might be right forAtopic DermatitisEczemaDNA Studies&Me
Testing effectiveness (Phase 2)Study completedNCT05003804What this trial is testingAllergic Disease Onset Prevention StudyWho this might be right forAtopic DermatitisType 1 Hypersensitivity Siolta Therapeutics, Inc. 283
Testing effectiveness (Phase 2)UnknownNCT05905133What this trial is testingEvaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe ADWho this might be right forAtopic Dermatitis Connect Biopharm LLC 360
Large-scale testing (Phase 3)Study completedNCT03745638What this trial is testingTopical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis Incyte Corporation 631
Not applicableEnded earlyNCT05639738What this trial is testingAssessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From ADWho this might be right forDermatitis, Atopic Pierre Fabre Dermo Cosmetique 12
Early research (Phase 1)Study completedNCT01702181What this trial is testingA Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic DermatitisWho this might be right forAtopic Dermatitis Otsuka Pharmaceutical Development & Commercialization, Inc. 92
Not applicableWithdrawnNCT00378300What this trial is testingThe Effects of Probiotics in Atopic DermatitisWho this might be right forAtopic Dermatitis University of California, Los Angeles
Large-scale testing (Phase 3)Not Yet RecruitingNCT07767253What this trial is testingEvaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)Who this might be right forDermatitis, Atopic Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 246
Not applicableLooking for participantsNCT07444801What this trial is testingIntervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital ImpactWho this might be right forAtopic Dermatitis (Moderate-to-severe) Involving the Genital Region University Hospital Schleswig-Holstein 30
Early research (Phase 1)Study completedNCT02379507What this trial is testingDEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot StudyWho this might be right forEczema Medicus Research, LLC 20
Not applicableStudy completedNCT04218877What this trial is testingThe Factors Affecting Atopic Dermatitis in Children Age 1-3Who this might be right forAtopic Dermatitis Akusherstvo Pro 300
Post-approval studies (Phase 4)Study completedNCT03293030What this trial is testingImmunogenetic Profiling of Dupilumab for the Treatment of Atopic DermatitisWho this might be right forAtopic DermatitisAtopic Dermatitis EczemaEczema+1 more University of California, San Francisco 17